Ongoing clinical trials and approved products targeting Amyloid, in radioligand therapy and PET/SPECT imaging. Data as of 26 October 2026.
| Amyvid, Vizamyl, Neuraceq[18F]florbetapir, flutemetamol, florbetaben | Lilly, GE HealthCare, Life Molecular Imaging | marketed | US EU FR JP |
| Trial | Phase | Status | Sponsor | Countries |
|---|---|---|---|---|
| [18F]FlorbetazineNCT07764679 · Alzheimer's disease and cognitive disorders | Phase 3 | Recruiting | HTA Co., Ltd. | 1 |
| Amyloid tracersNCT07873463 · Alzheimer's disease and cognitive disorders | Phase 2 | Not yet recruiting | GE Healthcare | 1 |
| ADRC PET · Amyloid tracersNCT07758660 · Alzheimer's disease and cognitive disorders | Phase 2 | By invitation | Patrick Lao | 1 |
| ADVISe · Amyloid tracersNCT04576793 · Alzheimer's disease and cognitive disorders | Phase 2 | Recruiting | Columbia University | 1 |
| Amyloid tracersNCT04840979 · Alzheimer's disease and cognitive disorders | Phase 2 | Active, not recruiting | Columbia University | 1 |
| Amyloid tracersNCT05805839 · Neuroinflammation and multiple sclerosis | Phase 2 | By invitation | Mayo Clinic | 1 |
| Amyloid tracersNCT07012993 · Alzheimer's disease and cognitive disorders | Phase 2 | Recruiting | Akiva Mintz | 1 |
| Amyloid tracersNCT03068442 · Alzheimer's disease and cognitive disorders | Phase 2 | Active, not recruiting | Scott Mcnally | 1 |
| PiB ADC · Amyloid tracersNCT03503331 · Alzheimer's disease and cognitive disorders | Phase 2 | Recruiting | University of Alabama at Birmingham | 1 |
| Amyloid tracers2025-522348-42-00 · Other | Phase 2 | Recruiting | Amsterdam UMC Stichting | 1 |
| Amyloid tracersNCT07787169 · Alzheimer's disease and cognitive disorders | Phase 1 | Recruiting | Eli Lilly and Company | 3 |
| HEAD · Amyloid tracersNCT05361382 · Alzheimer's disease and cognitive disorders | Phase 1 | Active, not recruiting | Tharick Pascoal | 3 |
| Amyloid tracers2023-503705-10-00 · Alzheimer's disease and cognitive disorders | Phase 1 | Recruiting | Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V. | 1 |
| Amyloid tracersNCT04263337 · Stroke and trauma | Phase 1 | Active, not recruiting | University of North Carolina, Chapel Hill | 1 |
| Amyloid tracersNCT04396873 · Alzheimer's disease and cognitive disorders | Phase 1 | Recruiting | National Institute of Mental Health (NIMH) | 1 |
| Amyloid tracers2024-519961-23-00 · Alzheimer's disease and cognitive disorders | Phase 1 | Not yet recruiting | Barcelonabeta Brain Research Center | 1 |
| Amyloid tracersNCT06303921 · Other | Phase 1 | Recruiting | University of Pennsylvania | 1 |
| Amyloid tracersNCT06932809 · Other | Phase 1 | Recruiting | University of Pennsylvania | 1 |
| Amyloid tracersNCT06974877 · Other | Phase 1 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Amyloid tracersNCT07169630 · Alzheimer's disease and cognitive disorders | Phase 1 | Recruiting | National Institute of Mental Health (NIMH) | 1 |
| Amyloid tracersNCT06032026 · Other | Phase 1 | Recruiting | University of Pennsylvania | 1 |
| Amyloid tracersNCT04768101 · Parkinson's disease and parkinsonian syndromes | Phase 1 | Active, not recruiting | Vanderbilt University Medical Center | 1 |
| RMX-VH · Amyloid tracersNCT07733674 · Brain (glioma, medulloblastoma…) | Phase 1 | Recruiting | Radiomedix, Inc. | 1 |
| EPSMS · Amyloid tracersNCT04390009 · Neuroinflammation and multiple sclerosis | Phase 1 | Recruiting | Brain Health Alliance | 1 |
| FUS-AD · Amyloid tracersNCT06600880 · Alzheimer's disease and cognitive disorders | Phase 1 | Not yet recruiting | Columbia University | 1 |
| IDV of tau-PET · Amyloid tracersNCT06618872 · Alzheimer's disease and cognitive disorders | No phase | Recruiting | University Hospital, Geneva | 1 |
| BioFINDER2 · Amyloid tracersNCT03174938 · Alzheimer's disease and cognitive disorders | No phase | Recruiting | Skane University Hospital | 1 |
| SEED-AD · Amyloid tracersNCT03821857 · Alzheimer's disease and cognitive disorders | No phase | Recruiting | Mayo Clinic | 1 |
| GliSyn · Amyloid tracersNCT05911178 · Alzheimer's disease and cognitive disorders | No phase | Active, not recruiting | Centre Hospitalier St Anne | 1 |
| Amyloid tracersNCT03582488 · Parkinson's disease and parkinsonian syndromes | No phase | By invitation | Kejal Kantarci | 1 |
| Amyloid tracersNCT01606488 · Alzheimer's disease and cognitive disorders | No phase | Active, not recruiting | University of California, San Francisco | 1 |
| Amyloid tracersNCT02740634 · Alzheimer's disease and cognitive disorders | No phase | Recruiting | Mayo Clinic | 1 |
| MGUS-PET · Amyloid tracersNCT07624760 · Myeloma | No phase | Not yet recruiting | University of Zurich | 1 |
Amyloid. Theranostic Atlas, LaRadiopharmacie.fr. Data as of 26 October 2026. https://theranosticatlas.com/target/amyloid/ (accessed [date]).
A monitoring tool with no regulatory value: check every item at its source.